To investigate how IGF-1 contributes to PD-L1 regulation, we tested effects of inhibiting signaling pathways of IGF-1R and it’s downstream effectors MEK-ERK and AKT in DU145 prostate cancer cells. The gene discussed is AKT1; the disease is prostate carcinoma.